Apt Medical Inc. (688617.SS) – Corporate Update
Trading Activity
- Last 24‑hour performance: 0 % change; price at CNY 256.47.
- Total shares outstanding: 136.5 million.
- Market capitalization: CNY 35.1 billion.
- Volume traded in last 24 h: CNY 285.5 million.
- Price change since end‑of‑month: +5.73 %.
Technical Indicators
- 200‑day simple moving average: CNY 221.87.
- 52‑week high: CNY 337.20 (recorded 24 Oct 2025).
- 52‑week low: CNY 176.28 (recorded 29 Jun 2026).
Recent Corporate Development
Apt Medical Inc. announced a significant share purchase by its majority shareholder, Shenzhen Mindray Technology Holding Co.
- Purchase details: Mindray acquired > 0.5 million shares in a large‑block transaction on the Shanghai Stock Exchange.
- Purchase price: Below the closing market level, representing a discount of approximately 12 %.
- Resulting ownership: Mindray’s stake increased to just under 28 %.
This transaction is part of Mindray’s strategy to strengthen its presence in the cardiovascular device and consumable sector following its earlier acquisition of Apt Medical. The deal is viewed as a reinforcement of confidence in Apt Medical’s prospects and a step toward deeper collaboration in research, distribution, and supply‑chain integration.
Financial highlights post‑acquisition indicate that revenue and net profit have continued to grow at a robust pace, with profitability metrics remaining healthy.
Related Stock Performance (Last 24 h)
| Ticker | Trading Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|
| Jiangsu Leasing (600901.SS) | 0 % | CNY 7.07 | CNY 42 billion | 12.18 |
| Sinotrans -H (0598.HK) | -1.27 % | HKD 4.22 | HKD 49.2 billion | 6.89 |
| Yangzhou Yangjie Electroni (300373.SZ) | 0 % | CNY 75.6 | CNY 41.8 billion | 29.34 |
| Shenzhen New Industries Bi (300832.SZ) | 0 % | CNY 53.6 | CNY 41.9 billion | 22.7 |
| Fiberhome Telecom Tech (600498.SS) | 0 % | CNY 30.11 | CNY 41.7 billion | 118.92 |
Additional note on Shenzhen New Industries Bi: The company has announced a planned direct‑offer share issuance to the Kunshan State‑owned Investment Group, shifting its governance structure toward a significant local state stake. This move aims to stabilize governance, improve the capital structure, reduce financial pressure, and enhance focus on core technologies such as advanced OLED and high‑value display segments. The change aligns with national policies supporting high‑tech, innovation‑driven enterprises and the transition of China’s manufacturing base toward higher‑added value and sustainable growth.
Company Profile
Apt Medical Inc. is a Shanghai‑based Chinese biotechnology company. The firm specializes in developing innovative solutions for various diseases, with a particular focus on cardiovascular health. Apt Medical is listed on the Shanghai Stock Exchange (ticker 688617.SS).
